Navigation Links
Eppendorf Research Series 2100 Fixed-volume Pipette, 500 l

ProductsEppendorf Research Series 2100 Fixed-volume Pipette, 500 l
Company Eppendorf North America
Item Eppendorf Research Series 2100 Fixed-volume Pipette, 500 l
Features 
Description Inquire
Info Eppendorf North America
Customer Service: (800) 645-3050
Web site: http://www.eppendorfna.com/home/

Related medicine products :

1. Eppendorf Thermomixer
2. Eppendorf Thermomixer R
3. Eppendorf ThermoStat Plus, without block
4. Eppendorf Refrigerated Multipurpose Centrifuge Model 5804R
5. Eppendorf Refrigerated Multipurpose Centrifuge Model 5810R
6. Eppendorf Heat Sealing Film
7. Eppendorf heat sealing film
8. Eppendorf PCR film, self adhesive
9. Eppendorf Heat Sealing Foil
10. Eppendorf PCR foil, self adhesive
11. Eppendorf Sealing Mat 96
...ng system especially designed for surgical monitor...ier has 16 channels and is equipped with two headb...can be independently configured as either a true r...r amplifiers are based on the Firewire (IEEE1394TM...
...etes management software - was designed by practic...vement tool helps diabetes care providers achieve ...cine with technology by providing a state-of-the-a...rmation technology product. This diabetes softwar...
...making decisions about insulin dosages and other m...ions are guided by data from blood glucose tests a... that can be seen by you and your Health Care Prov...graphical formats. The FreeStyle CoPilot System ma...
The Ex-PRESS is a mini glaucoma shunt that provides a simplified,method of filtration surgery for patients with open angle glaucoma.,Similar to trabeculectomy, the shunt reduces the intraocular
Medicine Products:
(Date:9/5/2008)...USTON - Lung cancer risk prediction models are enh...and by measuring DNA repair capacity, according to...ersity of Texas M. D. Anderson Cancer Center in tw...issue of Cancer Prevention Research . , In the ...hers found unique results based on increased expos...
(Date:9/4/2008)...New York, NY, September 5, 2008Private Medicare Ad...rcent more per enrollee in 2008 compared to what t...l Medicare fee-for-service program, according to a...he payment reductions to MA plans mandated by the ...ct of 2008 (MIPPA) scheduled to take effect begin...
(Date:9/4/2008)...ings of 3 studies focus on brain and pancreatic tu...ws) -- Potentially groundbreaking discoveries invo...he brain cancer glioblastoma and pancreatic cancer...earchers say. , "These studies represent the m... type and provide a detailed genetic map of these ...
(Date:9/4/2008)...PACIFIC PALISADES, Calif., Sept. 4 /PRNewswire/ --...recognized authority in the field of weight,contro...s Who in,California," "Who,s Who in The West," "Wh...o,s Who in Medicine and Health Care" and other hon...his expertise to exposing the,inaccurate, misleadi...
Breaking Medicine News(10 mins):Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
...ople in the United States are on waiting lists for... death of a matching donor, but more and more peop...t year nearly 7,000 people donated a kidney, segme...elp someone in need of a transplant. In fact at so...
...diabetics in China is smaller than that of many ot...na had around 23.8 million diabetics// of age betw...tween 40 and 59 are increasing in China, while dia...9 in developed countries," said Guo Xiaohui,who he...
...s the fourth leading cause of cancer deaths in the...ually affected // It is one of the most deadly ca...it has spread to other parts. Only about five perc...atients survive the first five years after being d...
...esting based on the ‘survival of the fittest’ theo...th a motive to nurture// the healthy ones, has bor...Couple, the first in UK, after successfully employ... This method proved a blessing to the parents in ...
Other Medicine News:Health News:Researchers Study Reimbursing Living Organ Donors for Out-of-Pocket Expenses 2Health News:Researchers Study Reimbursing Living Organ Donors for Out-of-Pocket Expenses 3
(Date:9/4/2008)... 4 /- Southern Research Institute,tod...h (NIH) has selected,the organization to participa...roduction Center Network (MLPCN). The MLPCN -- a c...lecular Libraries Program which is,designed to ben... the human,genome and validate future targets for ...
(Date:9/4/2008)...ent Identification for Targeted Therapies ...t HUNTINGTON BEACH, Calif., and AMSTERDAM, Neth...leader in molecular cancer diagnostics,today anno...ic test that,allows physicians to quantitatively d...n receptor (ER), progesterone receptor (PR) and Hu...
(Date:9/3/2008)...heumatology Research and Education Foundation,s W...es in Detecting, Treating and ...- For the first time during its,unprecedented init...e,American College of Rheumatology Research and Ed...quired from research funded by the Within Our,Reac...
(Date:9/3/2008)... Multaq(R) (dronedarone) decreased the risk of,str...atrial flutter already adequately tre..., Sept. 3 /- The results of...tudy were presented today at,the clinical trial up...,congress 2008, in Munich, Germany. Previous resul...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Statement by Lance Armstrong on Cancer Diagnosis of Senator Kennedy 19933 1Educational Drive Cut Death Rate From Sepsis 19930 1Educational Drive Cut Death Rate From Sepsis 19930 2Study analyzed SYMBICORT in children with persistent asthma 19926 1Study analyzed SYMBICORT in children with persistent asthma 19926 2Study analyzed SYMBICORT in children with persistent asthma 19926 3Ambulatory Services of America Inc Announces Joint Venture With Denton Cancer Center LP 19922 1Ambulatory Services of America Inc Announces Joint Venture With Denton Cancer Center LP 19922 2
...ne Shows Strong Immune Response, Protection,Agains... 2007 /PRNewswire-FirstCall/ -- Novavax,Inc.,s vir... immune,response and provided protection against t...e- clinical data published in the online,edition o...ted in three animal models, including,the ferret, ...
...lif., April 03, 2007,/PRNewswire-FirstCall/ -- Cel...ults from its second multi-center Phase 2 trial of...uated escalating doses,of the immunotherapy in 80 ...te cancer (HRPC). Additional follow-up of,the 22 p...o that,being employed in the company,s ongoing Pha...
Other Medicine Technology:Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 2Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 3Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 4Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3